Key points {#Sec1}
==========

The association between quantitative radiomic features from digital breast tomosynthesis and Ki-67 expression of breast cancer was investigated.A combination of five radiomic features yielded an area under the curve at receiver operating characteristics analysis of 0.676 to for high *versus* low Ki-67 expression.Thirty-four features were significantly correlated with Ki-67 expression.

Background {#Sec2}
==========

The proliferation marker Ki-67 is an independent predictive and prognostic factor for breast cancer patients \[[@CR1]\]. Although several attempts are ongoing toward personalised medicine with complex approaches to find the best biomarkers for an individual patient, Ki-67 has been shown to successfully guide the optimal treatment for each subject \[[@CR2], [@CR3]\]. Indeed, whilst a poor prognosis in breast cancer patients is usually associated with high Ki-67 expression, patients with high Ki-67 expression are likely to respond better to chemotherapy. The first evaluation of Ki-67 on breast cancer patients is based on immunohistochemistry obtained often on vacuum/assisted breast biopsy (VABB) or core biopsy. However, tumoural heterogeneity and limited extent of the retrieved samples explain why the samples might be not representative of the entire tumour bulk and hence of its biology.

In recent years, the increasing use of radiomics in medical imaging to identify biomarkers for prognosis and therapy monitoring relies on the reasonable assumption that tumour characteristics, in particular its heterogeneity, can be assessed directly from a clinical medical image (which captures the entire tumour) rather than from a relatively limited tissue sample. Radiomics refers to the extraction and analysis of large amount of quantitative imaging features from medical images and has been extensively discussed in recent literature \[[@CR4], [@CR5]\]. In an exploratory study, it has been proposed that quantitative imaging features extracted from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) are associated with breast cancer Ki-67 expression \[[@CR6]\]. However, women with breast cancer are more likely to have DBT available instead of MRI which is not performed routinely in all breast cancer cases. Therefore, the aim of this study was to investigate whether quantitative radiomic features extracted from DBT images are associated with Ki-67 expression of breast cancer.

Methods {#Sec3}
=======

Patients {#Sec4}
--------

This prospective study was approved by the institutional review board, and written informed consent requirement was acquired (CER009/2018). The study cohort included 70 patients diagnosed with invasive breast cancer (confirmed at histopathology after surgery) from January to December 2018. Patient characteristics are reported in Table [1](#Tab1){ref-type="table"}.The patient group included cancers with 40 low Ki-67 expression (Ki-67 proliferation index \< 14%) and 30 high Ki-67 expression (Ki-67 proliferation index ≥ 14%). The cut-off value of 14% for Ki-67 proliferation index was selected to be consistent with recent literature on MRI \[[@CR6]\].Table 1Patients and tumour characteristicsCharacteristicMean (range)Number of patientsAge62 (26--86) years70Histological subtype Invasive ductal carcinoma52 Infiltrating lobular carcinoma8 Other types10Histological grade (Nottingham's scale) High (G3)16 Intermediate (G2)28 Low (G1)26Tumour size15 (4--55) mm \< 10 mm12 10--19 mm45 20--29 mm5 ≥ 30 mm8Nodal status Negative48 Positive16 Unknown6

Digital breast tomosynthesis {#Sec5}
----------------------------

Tomosynthesis acquisitions were performed with reconstructed synthesised two-dimensional images, using a commercially available equipment (Hologic, Selenia Dimensions, Bedford, MA, USA). Radiomic analysis was performed as previously done on DBT images by Tagliafico et al. \[[@CR7]\] who firstly applied and reported a radiomic approach to DBT to differentiate normal from malignant breast tissue in patients with dense breasts \[[@CR5]\].

Image analysis {#Sec6}
--------------

Radiomic analysis was performed on all DBT images; ROI positioned on 2D images were transferred to the central tomo slices using software (Osirix and 3D Slicer 4.7), within manually selected regions of interest (ROIs) including all DBT areas subjectively attributed to malignant tissue. ROIs were placed by two researchers (AT and FV) with expertise in quantitative image analysis (9 and 5 years of experience, respectively). ROI tracing on the single slice of the central digital breast tomosynthesis projection images was adjusted manually, if necessary \[[@CR7]\]. An example is shown in Fig. [1](#Fig1){ref-type="fig"}. From DBT images, we extracted 106 features using an open-source software platform for medical image informatics, image processing, and three-dimensional visualisation (3D Slicer 4.7; [www.slicer.org](http://www.slicer.org)) built over two decades through support from the National Institutes of Health and a worldwide developer community \[[@CR8]\]. Details of the mathematical notations and the computation of these texture features have been previously published \[[@CR9]\]. All these features were normalised to a standard range before being used in a statistical software. Fig. 1Medio-lateral oblique view (two-dimensional image). On the left, the circle highlights the suspicious spiculated lesion. On the right, the region of interest (coloured in green) defined by the reader. The region of interest was then transferred to the central tomo slices using a software and adjusted if necessary

Statistical analysis {#Sec7}
--------------------

Least absolute shrinkage and selection operator (LASSO) method \[[@CR10]\] to select the most predictive feature set for the classifiers was used, and low *versus* high Ki-67 expression prediction was evaluated by receiver operating characteristic (ROC) analysis. For significant features, a multivariate analysis and multiregression correlation analysis and the results in terms of true positive and false positive for the significant features were done. Accuracy was measured using ROC analysis to estimate the area under the curve (AUC). Radiomic features that significantly differentiated low *versus* high Ki-67 expression, based on the mean value in each group, were considered if AUC was \> 0.6. Ninety-five percent confidence intervals (95% CIs) were calculated. Using a statistical software, *p* values below 0.05 were considered statistically significant. Correlation analysis and univariate linear regression were performed to determine the association between the individual radiomic features and the Ki-67 expression. Statistical tests were done using a statistical software (STATA MP, StataCorp, 4905 Lakeway Dr, College Station, TX, USA, and MedCalc).

Results {#Sec8}
=======

There was no significant difference in age between the low Ki-67 group and the high Ki-67 group (*p* = 0.523). On the basis of the multivariate logistic regression analysis, the clinical factors with *p* \< 0.05 were used to build the clinical model. Calibration was plotted to explore the predictive accuracy by bootstrapping with 1000 resamples. The list of radiomic features with significant *p* values and AUC \> 0.6 for discriminating low from high Ki-67 expression lesions is reported in Table [2](#Tab2){ref-type="table"} and Fig. [2](#Fig2){ref-type="fig"}.Table 2Values of feature parameters differetiating between low and high Ki-67 expression on digital breast tomosynthesisFeatureFeature classAUC*p* valueLower 95% CIUpper 95% CISphericityShape0.6130.0070.4620.764AutocorrelationGrey level co-occurrence matrix0.6250.0020.4740.776Interquartile rangeFirst order0.6330.0030.4810.784Robust mean absolute deviationFirst order0.6410.0090.4870.795Short-run high grey-level emphasisGrey level run length matrix0.6760.0010.5340.818Features were included if the area under the curve (AUC) was \> 0.6 with a *p* \< 0.05. *CI* Confidence intervalFig. 2Receiver operating characteristic curve of feature parameters differetiating between low and high Ki-67 expression on digtal breast tomosynthesis. Features were included if the area under the curve was \> 0.6 in association with statistical significance

In terms of the most significant features selected by the LASSO method to be correlated with Ki-67, 34 features were significantly (*p* ≤ 0.001) correlated with Ki-67 and 5 of these had a correlation coefficient of \> 0.5. These five features were median, total energy, different average, tenth percentile among first order features, and grey level co-occurrence matrix (GLCM) (Table [3](#Tab3){ref-type="table"}). Sphericity is a morphological feature describing the three-dimensional size and shape of the tumour, whereas autocorrelation is a measure of the magnitude of the fineness and coarseness of texture. Interquartile range and robust mean absolute deviation are first-order features representing the mean distance of all intensity values from the mean intensity calculated on the subset of image array with grey levels in-between, or equal to the 10th and 90th percentile representing intra-tumoural heterogeneity. Short-run high grey-level emphasis is a grey level run length matrix (GLRLM) feature and increases when the texture is dominated by short runs with high intensity levels likely also reflecting intra-tumoural heterogeneity.Table 3Values of the five features parameters with a correlation coefficient \> 0.5 and *p* \< 0.001Feature nameFeature classCorrelation coefficient*p* valueMedianFirst Order0.5360.001Total energyFirst Order0.6220.001Different averageFirst Order0.5010.00110th percentileFirst Order0.6580.001ContrastGrey level co-occurrence matrix0.6160.001

Table [4](#Tab4){ref-type="table"} reports the performances of the best five features of Table [2](#Tab2){ref-type="table"}.Table 4Performance metrics of the five features with area under the curve \> 0.6 to differentiate low and high Ki-67 expression on digital breast tomosynthesisFeatureFeature classAccuracySensitivitySpecificitySphericityShape0.6560.6450.673AutocorrelationGrey level co-occurrence matrix0.6770.6820.653Interquartile rangeFirst order0.6530.6610.631Robust mean absolute deviationFirst order0.6760.6890.631Short-run high grey-level emphasisGrey level run length matrix0.6980.7420.534

Discussion {#Sec9}
==========

The present study used DBT images to apply a radiomic approach aiming to assess if an association between breast cancer Ki-67 expression and radiomic features exists. Our findings show that after applying methods to select the most predictive features to differentiate low *versus* high Ki-67 expression, it is possible to identify several features with ROC-AUC values from 0.653 to 0.698 to differentiate patients with low *versus* high Ki-67 expression. We could speculate that with refinements in textural analysis techniques and increased reproducibility radiomic analysis, it may be possible to obtain an estimation of Ki-67 expression directly from DBT images even before biopsy, estimating the activity of the tumour (namely cell proliferation) directly from DBT images obtained at diagnosis. This hypothesis was already developed by a previous pilot study where quantitative radiomic imaging features of breast tumour extracted from DCE-MRI were associated with breast cancer Ki-67 expression \[[@CR6]\]. In the present study, we showed that using an imaging modality such as DBT, used in breast cancer screening and diagnosis and more widely available than MRI, it is possible to find an association between quantitative radiomic imaging features and Ki-67 expression. The data reported in the present study are encouraging because they support the hypothesis that radiomic features could predict Ki-67 expression of breast cancer (and hence an element of tumour biology) in a non-invasive manner.

We selected features that simultaneously resulted in an AUC \> 0.6 with a minimum *p* value of 0.05 in differentiating between low and high Ki-67 expression on DBT. This allowed us to identify five features with these requirements, whereas a previous study that was based on DCE-MRI found 13 features associated with Ki-67 expression (similarly meeting *p* \< 0.05 and AUC \> 0.6 criteria) \[[@CR6]\]. As a whole, the meaning of these features could be that high Ki-67-expressed lesions are more likely to be inherently heterogeneous. The five DBT-based features identified in this study differ from the DCE-MRI-based features, but they reflect intra-tumoural heterogeneity as well. Moreover, the type of information contained in MRI *versus* DBT images is different due to the different biophysical characteristics of the two imaging modalities.

Our study suggests that tumoural biological aggressiveness related to high Ki-67 expression can be evaluated on DBT, avoiding the need of contrast media injection which is used for MRI. In this study, we did not find features with AUC higher than 0.7; therefore, it seems possible that radiomic features on DBT do not strongly discriminate low and high Ki-67-expressing breast cancers and further evaluation in larger studies is needed. However, future studies could examine the added value of radiomic evaluation (added to other prognostic factors) in tumoural aggressiveness assessment. A previous study \[[@CR7]\] on radiomics and DBT performed in women with dense breast found a correlation between radiomic features and tumour size and oestrogen receptors: three radiomic features (energy, entropy, and dissimilarity) correlated with tumour size and entropy correlated with oestrogen receptor status. This study supports the use of radiomics to assess tumoural characteristics on breast cancer patients on digital breast tomosynthesis in further studies based on larger datasets to extend these exploratory data.

This study has several limitations. The first limitation is that images are from a single vendor and acquired at a single institution; therefore, a multicentric study would be important to assess if these results are valid on a larger scale and could be generalised. The second limitation is that tumour lesions were manually segmented by human readers and reproducibility was not assessed. As a major limitation, we acknowledge that there are no data on reproducibility in this study, although the methods of the present paper were already tested in our previous paper (intra-observer agreement of 0.78) \[[@CR7]\].

The third limitation is that we have few published data regarding DBT and radiomics, and this is one of the first studies exploring associations between radiomic features and Ki-67 expression on DBT; therefore, comparison with previously published data is limited.

However, the results of this study are not sufficient to make decisions in clinical practice because of the relatively limited AUC values found for the features and because of these results need to be replicated by other researchers. In addition, the study design was not intended to create an algorithm or a radiomic nomogram to differentiate low from high Ki-67 expression. We acknowledge the exploratory nature of the present research.

However, this study could be used for future study not only as a proof-of concept investigation but also as a reference for comparisons.

In terms of strengths, whilst noting this as an exploratory study, it is nonetheless the first study to use data from images prospectively acquired with the same technique reducing biases due to image acquisition geometry and reconstruction algorithm typical of DBT prototypes. Also, we used a freely available software enhancing the ability to replicate the research by other independent groups.

In conclusion, this study showed that some quantitative imaging features extracted from DBT acquired in clinical practice are associated with breast cancer Ki-67 expression. Our findings can inform new studies on DBT-based radiomics and breast cancer biology.
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